Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease

Mayo Clinic Proceedings

Volumn 75, Issue 10, 2000, Pages 1020-1026

  Blute, Michael L ^a,b   Amling, Christopher L ^a   Bryant, Sandra C ^a   Zincke, Horst ^a  

^a MAYO CLINIC   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ENUCLEATION; FEMALE; FOLLOW UP; HERNIA; HUMAN; KIDNEY CARCINOMA; KIDNEY PRESERVATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; NEPHRON; POSTOPERATIVE COMPLICATION; PROTEINURIA; SURGICAL TECHNIQUE; TREATMENT OUTCOME; URINE EXTRAVASATION; VON HIPPEL LINDAU DISEASE; WOUND INFECTION; BILATERAL CANCER; CANCER CLASSIFICATION; CANCER RISK; CANCER SPECIFIC SURVIVAL; DISEASE COURSE; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; KIDNEY TUMOR; LOCAL RECURRENCE FREE SURVIVAL; METASTASIS FREE SURVIVAL; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RENAL CELL CARCINOMA; TREATMENT DURATION; TUMOR VOLUME; VERY ELDERLY;

EID: 0033795934     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.10.1020     Document Type: Article

References (17)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. ÇA Cancer J Clin. 2000;50:7-33.
2. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281: 1628-1631.
3. Marshall FF, Stewart AK, Menck HR, American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base: report on kidney cancers. Cancer. 1997;80:2167-2174.
4. McDonald MW. Current therapy for renal cell carcinoma. J Urol. 1982:127:211-217.
5. Jacobs SC, Berg SI, Lawson RK. Synchronous bilateral renal cell carcinoma: total surgical excision. Cancer. 1980;46:2341-2345.
6. Novick AC, Streem S, Montie JE, et al. Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients .J Urol. 1989:141:835-839.
7. Kerr LA, Zincke H. Bilateral renal cell cancer treated surgically is associated with favorable disease outcome. Int J Oncol. 1993:2: 1009-1012.
8. Dechet CB, Sebo T, Farrow G, Blute ML, Engen DE, Zincke H. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J U ml. 1999:162:1282-1284.
9. Black J, Rotellar C, Rakowski TA, Winchester JF. Bilateral nephrectomy and dialysis as an option lor patients with bilateral renal cancer. Nephron. 1988:49:150-153.
10. Wickham JE. Conservative renal surgery for adenocarcinoma: the place of bench surgery. BrJUrol. 1975;47:25-36.
11. Marberger M, Pugh RC, Auvert J, et al. Conservative surgery of renal carcinoma: the EIRSS experience. Br J Urol. 1981:53:528-532.
12. Lerner SE, Hawkins CA, Blute ML, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol. 1996; 155: i 868-1873.
13. Mukamel E, Konichezky M, Engelstein D, Servadio C. Incidental small renal tumors accompanying clinically overt renal cell carcinoma. / Urol. 1988:140:22-24.
14. Kletscher BA, Qian J, Bostwick DO, Andrews PE, Zincke H. Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J Urol. 1995;153:904-906.
15. Lerner SE, Tsai H, Flanigan RC, Trump DL, Fleischmann J. Renal cell carcinoma: considerations for nephron-sparing surgery. Urology. 1995;45:574-577.
16. Campbell SC, Fichtner J, Novick AC, et al. Intraoperative evaluation of renal cell carcinoma: a prospective study of the role of ultrasonography and histopathological frozen sections. ./ Urol. 1996;155:1191-1195.
17. Steinbach F, Stöckle M, Kiewel R, Storkel S, Stein R, Hohenfellner R. Prognostic parameters of renal cell carcinoma: clinicopathologic and DNA image cytometric analysis in 133 pT3a cases. Eur Urol. 1993;24:279-285.